The present invention relates to infusion pumps for medical treatments generally and to handling of air and air in the pump system in particular.
An intravenous (IV) system typically includes a bag holding the fluids to be infused, tubes connecting the bag to the patient and a pump to regulate the flow of fluids into the patient. Such pumps are utilized for providing many types of fluid, chemotherapy being but one example.
The chemicals for chemotherapy are typically very expensive and very toxic. This requires that minimal amounts of the chemicals be wasted and that the medical staff, who are generally healthy, not be exposed to the toxic drugs. Unfortunately, current pump technology does not ensure this.
The problem is that the toxic fluids generate air as they move through the IV tubes and only a small amount of air may be introduced into a patient's bloodstream. Current pumps have an air bubble detector, to detect the presence of air (as an air bubble) and to stop the operation of the pump as a result of a small amount of air (for example, 1 ml) passing to the patient within a pre-defined period of time (such as 15 min) or single bubbles that are more than a pre-determined size (0.2 ml as an example). The pump then alerts the medical staff, which detaches the tubes, refills them with fluid (usually by spilling some of the fluid into a container of some kind) removing the air bubbles in the process and restarts the pump. Unfortunately, patients receiving chemotherapy are very sensitive to contamination, which may happen when the tubes are detached.
Moreover, this procedure can expose the medical staff to the toxic fluids and air and it spills the expensive drugs. Moreover, detaching the tubes exposes them and can lead to contamination of the patient. Another issue is that the air bubbles tend to stop treatment in short intervals.
The following patent publications discuss various attempts to solve these problems, including adding traps for air in the pump and after the pump: U.S. Pat. No. 7,131,966 to Tamari, U.S. Pat. No. 4,954,256 to Degen et al, US 2002/0056675 to Hegde, U.S. Pat. No. 6,280,408 to Sipin, U.S. Pat. No. 5,308,333 to Skakoon, U.S. Pat. No. 7,048,720 to Thorne, Jr. et al and U.S. Pat. No. 4,927,411 to Pastrone et al.
There is therefore provided, in accordance with a preferred embodiment of the present invention, an intravenous pump system including an intravenous pump having an air bubble detector; a separate air trap module and a patient line. The air trap module is connectable to a set interface which is operatable upon by the intravenous pump. The air trap module includes an air chamber capable of receiving fluids and air, a plurality of valves controlling the flow of the fluids and air, and an air vent. The patient line is connectable to the air trap module and to a patient. The air trap module includes an actuator to control the state of the valves to enable, at least during a venting mode, the pump to push air out of the air chamber via the vent without disconnecting the patient from the patient line.
There is also provided, in accordance with a preferred embodiment of the present invention, an intravenous line including an air trap module at least connectable to a source of intravenous fluid, a set interface connectable to the air trap module and operatable upon by an intravenous pump, a return line connectable to the set interface and to the air trap module and a patient line connectable to the air trap module and to a patient.
Moreover, in accordance with a preferred embodiment of the present invention, the system includes a return line connectable to the set interface and to the air trap module.
Further, in accordance with a preferred embodiment of the present invention, at least during the venting mode, the pump pumps fluid through the return line and back into the air chamber.
Still further, in accordance with a preferred embodiment of the present invention, the valves include a venting valve at least to control the flow of air out of the air chamber, a patient valve controlling the patient line and a lower valve at least to control the flow of fluid from the air chamber to the set interface.
Moreover, in accordance with a preferred embodiment of the present invention, the venting valve is located generally at the top of the air trap module.
Additionally, in accordance with a preferred embodiment of the present invention, the air trap module includes a bypass path to pass incoming fluid to the set interface to be pumped into the air chamber via the return line when the venting valve is open.
Further, in accordance with a preferred embodiment of the present invention, the air chamber holds 2-4 ml.
Still further, in accordance with a preferred embodiment of the present invention, the actuator includes a unit to change the valves among a plurality of states.
Moreover, in accordance with a preferred embodiment of the present invention, one of the states is a treatment state during which at least the patient line valve is open, the venting valve is shut and the bypass path is closed. Another state is a priming state wherein the patient line valve is open, the venting valve is shut, the bypass path is closed and an upper fluid valve, near the top of the air chamber, is open. There may also be a sterilization state wherein all the valves are open.
Further, in accordance with a preferred embodiment of the present invention, the actuator may be either a manual dial or one or more electro mechanical actuators. For example, the electro mechanical actuators are controllable by the pump.
Still further, in accordance with a preferred embodiment of the present invention, the air detector of the pump detects the presence of air and controls the valves to change among treatment, venting and priming states accordingly.
Moreover, in accordance with a preferred embodiment of the present invention, there may be a unit to connect the air trap module upstream of the pump.
Alternatively, in accordance with a preferred embodiment of the present invention, the valves may alternatively include a venting valve at least to control the flow of air out of the air chamber, a patient valve controlling the patient line, an upper fluid valve, near the top of the air chamber, and a lower valve at least to control the flow of fluid from the air chamber to the set interface.
Further, in accordance with a preferred embodiment of the present invention, in the treatment state the patient and the lower valves are open and the venting and the upper valves are shut. In the priming state, the patient and upper valves are open and the venting and lower valves are shut. In the venting state, the patient and lower valves are closed and the venting and upper valves are open.
Still further, in accordance with a preferred embodiment of the present invention, the manual dial includes an actuator locking mechanism to lock the actuator between states.
Moreover, in accordance with a preferred embodiment of the present invention, the venting valve includes a buoy valve at least to keep fluid from exiting through the vent. The vent can be a swabbable valve connector.
Additionally, in accordance with a preferred embodiment of the present invention, the air chamber includes unit for indicating fluid/air level.
Further, in accordance with a preferred embodiment of the present invention, the air trap module includes a positioning connector to connect the air trap module in a predefined position relative to the pump. For example, the positioning connector can include an identifier to be sensed by the pump.
Moreover, in accordance with a preferred embodiment of the present invention, the line can include a unit to connect the air trap module upstream of the pump.
There is also provided, in accordance with a preferred embodiment of the present invention, a method for an intravenous pump. The method includes during venting of an air trap module, pumping a pre-defined volume downstream of the pump.
Moreover, in accordance with a preferred embodiment of the present invention, the pre-defined volume is a function of the volume of an air trap chamber forming part of the air trap module.
Further, in accordance with a preferred embodiment of the present invention, the method includes receiving input of the volume of a receiving collecting unit and determining when the collecting volume is at least close to filled as a function of multiple pumping cycles of the pre-determined volume.
The subject matter regarded as the invention is particularly pointed out and distinctly claimed in the concluding portion of the specification. The invention, however, both as to organization and method of operation, together with objects, features, and advantages thereof, may best be understood by reference to the following detailed description when read with the accompanying drawings in which:
It will be appreciated that for simplicity and clarity of illustration, elements shown in the figures have not necessarily been drawn to scale. For example, the dimensions of some of the elements may be exaggerated relative to other elements for clarity. Further, where considered appropriate, reference numerals may be repeated among the figures to indicate corresponding or analogous elements.
In the following detailed description, numerous specific details are set forth in order to provide a thorough understanding of the invention. However, it will be understood by those skilled in the art that the present invention may be practiced without these specific details. In other instances, well-known methods, procedures, and components have not been described in detail so as not to obscure the present invention.
Applicants have realized that adding a stand-alone air trap chamber, separate from the pump and as part of the tubing connecting the bag to the pump, may enable the air bubbles to be collected in one place, to be safely removed. Moreover, Applicants have realized that the fluid already in the tubes may be utilized to push the air out of the air trap chamber and into a closed container, thereby removing the air without detaching the tubes from the pump or from the patient and without the need to spill fluid to refill the tubes. As a result, there may be little or no contamination of the patient. For expensive drugs like chemotherapy drugs, the lack of spillage represents a significant savings, not to mention the fact that, with little or no spillage, the dosage prescribed is the dosage received.
In one embodiment, which has a bypass path, the bypass fluid may be returned to the air trap chamber to push the air out of the air trap. In another embodiment, the pump may pull the air out of the air trap chamber directly to the vent. In both cases, the air trap is refilled with fresh fluid.
The apparatus described below is particularly relevant for chemotherapy applications, where spillage is of great concern; however, it will be appreciated that the apparatus may be utilized for all types of infusion operations since the apparatus of the present invention may maintain a closed system which may minimize patient contamination. It will also minimize the time needed to remove air from the IV system.
It will be appreciated that, as described in more detail hereinbelow, the air removal and refilling of the fluid are all done by the pump operating in its normal (i.e. forward) mode of operation and without stopping all the pump standard alerts. This further enhances the safety of the patient while removing the air from the system.
Reference is now made to
Air trap module 12 may be connected to set interface 14, prior to pump 10 and above it, thereby to receive air flowing in the supply line 21. Air trap module 12 may have an air trap chamber 16 and a vent 18 therein, as well as a plurality of valves to control the flow of fluid into and out of air trap chamber 16 and to control the flow of air out of air trap chamber 16. In the embodiment of
In accordance with a preferred embodiment of the present invention, air trap module 12 may also have four line connections, a supply connection 20 to a supply line 21, a set interface connection 22 to tubing connected to set interface 14, a return connection 24 connectable to a return line 25 connected after set interface 14 and a patient connection 26 connectable to a patient line 27 connectable to the patient.
Air trap module 12 of
In general, there may be 3 operational modes, a treatment mode shown in
It will be appreciated that vent 18 and its associated venting valve 7 may be located generally at the top of air trap chamber 16, thereby to allow the air to rise and to be pulled out without squeezing air trap chamber 16.
In a further pre-operation mode (not shown in the figures), all valves 1-7 may be open, thereby connecting all internal passages. This may allow free flow of sterilization gases throughout module 16, a typical requirement for an ETO type of sterilization. Typically, this mode may be active only during manufacturing or by a specially trained technician and may no longer be accessible once regular operation begins.
Referring now to
Referring now to
As mentioned hereinabove, during treatment, the chemotherapy fluid may generate gases which form air bubbles in the flow, typically as the fluid flows from supply line 21. Air trap chamber 16 may trap these gases and may fill up. Thus,
In the venting mode, in accordance with a preferred embodiment of the present invention, the input to pump 10 may be switched to come directly from supply line 21, via bypass line 29, thereby to ensure that fluid may be pushed through return line 25 back into air trap chamber 16, to push the air out through vent 18. To enable this, bypass valve 5, return valve 6 and vent valve 7 are opened. Bypass valve 5 may provide fluid directly from supply line 21 through set interface 14 to return line 25 and return valve 6 may allow the fluid from return line 25 to flow back into air trap chamber 16, thereby filling air trap chamber 16 with fluid (indicated by arrow 34) which, in turn, may push the toxic air through valve 7 and out vent 18, preferably into a closed unit, such as syringe 19.
The remaining valves, supply valve 1, lower valve 4, upper valve 2 and patient valve 3, are all closed, to keep the air from the patient. Thus, with pump 10 pushing fluid, via return line 25, back into air trap chamber 16, the present invention may flush undesired air out of air trap chamber 16, without disengaging patient line 27 from the patient and without exposing staff members to any of the noxious air.
As mentioned hereinabove, during manufacture of any medical device, all passages of the device must be sterilized. For ETO sterilization, sterilization gases are passed through the device. In the present invention, when all the valves are open, the sterilization gases may pass from one section of the chamber to the next and thus, the device may be sterilized.
Reference is now made to
However, in this embodiment, there may be four valves 41-44 to air trap module 40, two controlling flow through air trap chamber 16 and two controlling the output flow, either to patient line 27 or to vent 18. The two controlling flow through air trap chamber 16 may be an upper valve 41 controlling fluid and air flowing from the top of air trap chamber 16 and a lower valve 42 controlling fluid flow from air trap chamber 16 into set interface 14. The two controlling the output may be a patient valve 43 controlling fluid flow into the patient, and a venting valve 44 venting undesired air out of air trap module 40.
Referring now to
Referring now to
In the venting mode, with air trap module 40 full of air, the air may be pumped by pump 10 out of upper valve 41, through return line 25 and out through vent 18. Thus, lower valve 42 and patient valve 43 are closed, to keep air from the patient, and upper valve 41 and vent valve 44 are opened. As the air is being removed, fluid will begin to flow from supply line 21, filling air trap chamber 16 and return line 25, such that, once all of the air is removed, the system may return to the treatment mode.
It will be appreciated that, in this embodiment, the air detector of pump 10 may be shut off during removal of the air, so as not to detect the air flowing past the pump during the removal process.
Venting valve 7 or 44 may be any suitable venting valve. For example, it may have a buoy to prevent the flow fluid out vent 18 once all of the air has been removed. If the buoy is a one directional buoy, the buoy may rise up the valve as the fluids rise in air chamber 16 and may block the opening of valve 7 or 44 as a result. This may keep fluids from being vented into the collection bag or syringe 19. If the buoy is a two directional buoy, it may also prevent the return of existed fluids collected in a collection bag back to the air trap chamber system. Vent 18 may have a check valve, typically a swabbable valve connector, which may prevent accidental air discharge.
It will be appreciated that, in both embodiments, air trap chamber 16 has two valves, lower valve 4 or 42 and upper valve 2 or 41 to control the flow of fluid and/or air, depending on the operational mode. It will be appreciated that this enables air trap module 12 or 40 to handle both the presence of fluid and the presence of air without having to disconnect the patient from patient line 27.
It will further be appreciated that air trap chamber 16 may provide a buffer for collecting air. Its size may define the amount of air to be collected which, in turn, may define the amount of time the medical staff has between air removals. It is possible that, with the existence of this buffer per patient, the medical staff may be able to clear the various air trap chambers of a treatment room of patients before the various air trap chambers 16 fill up completely.
It will further be appreciated that air trap modules 12 and 40 may be connected to any suitable type of pump. For each of the operational modes, pump 10 merely pumps in a forward direction; where the fluid or air goes is controlled by valves 1-7 or 41-44.
It will further be appreciated that, for air trap module 12, air may reach the air detector of pump 10 which may cause pump 10 to stop operating. However, since, during the venting operation, the substance flowing through the pump is fluid from the bypass path, the air detector of pump 10 may remain operative during venting of the air.
It will further be appreciated that valves 1-7 or 41-44 may be implemented mechanically or electro-mechanically. In the mechanical configuration, there may preferably be a single actuator controlling all valves states. In the electro-mechanical case, each valve may be separately programmed or they may be programmed to open or close as a group. In this embodiment, there may be an external actuator connected to pump 10.
Reference is now made to
Optionally, stick 58 may include an identification element 57, such as a small magnet, therein and holder 54 may include an identifying sensor 59, such as a Hall effect sensor. Sensor 59 may sense the presence or absence of identification element 57 and may provide its output to pump 10. Element 57 and sensor 59 may enable automatic set recognition when air trap module 12 or 40 may be attached on to the pump.
It will be appreciated that stick 53 may allow the air trap module to be maintained in its correct position, upstream of the pump, allowing proper air accumulation in air chamber 16. Thus, when the AT chamber is full with air and bubbles are starting to flow into the pump, the internal air bubble sensor of pump 10 may detect the bubbles and may stop pumping fluid, thereby protecting the patient. Stick 53 is only one embodiment; other fastening elements may maintain proper air accumulation as well
The knob in
Dial knob 56 may have multiple positions, each controlling a different mode of operation. Four positions are shown, for infusion, venting, priming and an optional sterilization mode (labeled ETO). As will be described in more detail hereinbelow, as knob 56 moves from one position to another, the valves open and close to come to the states discussed hereinabove. It will be appreciated that knob 56 is a single handle which provides all modes. This may provide a simple and relatively reliable operation.
Module 50 may comprise a top cover 70, dial knob 56, a dial 72, seven valve spools 74, a hive 76 of holes, a flexible seal membrane 78, a main body 80 and a bottom cover 82. Note that volume 58 is formed when bottom cover 82 is connected to body 80.
It will be appreciated that other configurations of valves are possible and are incorporated within the present invention.
Spool 74 may be held in place by one of holes 84 in hive 76 and may be held against flexible seal membrane 78. Dial 72 may comprise an undulating underside 90 which may have recesses 92 and protrusions 94, where protrusions 94 may press each spool 74 down into seal membrane 78 while recesses 92 may allow each spool 74 to rise, typically pushed back by seal membrane 78. The arrangement of the recesses 92 and protrusions 94 may determine which valves open and which close for each of the operational modes.
In accordance with one embodiment of the present invention, there may be a concentric valve configuration comprising a first conduit 96, optionally vertical, in the center of the valve module and a second conduit 98, optionally horizontal, connected together via a circular ditch-like groove 100. The top circular lips of conduit 96 and groove 100 may be located underneath membrane 78.
In
It will further be appreciated that the location of protrusions 94 with respect to each other may enable the present invention to provide a double action safety feature, such as a make before break feature, for changing from one mode to another. Thus, recesses 92 may be located such that, when turning from one mode to another, certain released spools 74 may be closed by their respective protrusions 94 before other spools 74 may be opened by their respective recesses 92. This may enable one mode disengage completely before the next mode engages, which may be useful for the venting mode which may cause a buildup of pressure in air trap module 16. This pressure may be released when returning from venting mode back to treatment mode by ensuring that closed supply valve 1 will open (to release pressure back into supply line 21 instead of into the patient) before open return valve 6 is closed and closed patient valve 3 is opened.
During priming, as shown in
During venting (
In the optional sterilization mode (
As shown in
In an alternative embodiment, protrusion 120 may be part of cover 70 and assembly recess 122 may be part of dial 72.
Typically, air trap module 50 may remain in the sterilization mode until first use, at which point the user may switch the dial to one of the operating modes. When this happens, dial 72 may move out of assembly recess 122, resulting in snap edge 124 moving off of operating range edge 126 and into an operating range defined by range edge 126 and another range edge 127. The described mechanism prevents switching the air trap module back to ETO mode once the user has switched it to one of the other operational modes (e.g. treatment, priming or venting). However, it is possible to overcome this restriction, particularly to test the module during assembly.
It will be appreciated that the embodiment of
In an alternative embodiment, the electro mechanical valve actuators may have a linear or rotary construction.
The electro mechanical valve actuators may be assembled in a separate assembly that may be snapped onto the air trap module. It may be constructed for multiple uses and may also have a secondary, manual actuator for when the electro mechanical actuator is not working. In this embodiment, the pump may control the operation of the air trap module and may activate the various valves according to the modes discussed hereinabove. The air detector of the pump may detect the presence of air and may control the valves to change from the treatment to venting and back. It may also control the priming state. In this embodiment, the air trap module may have 7 or 4 valves, as desired.
In one embodiment, during venting, the pump may drive an amount of fluid that is equivalent to the volume of air trap chamber 50 plus a small amount. This is a safety feature to prevent the pump from pushing the piston of the syringe out and spilling the medicine if the nurse forgets to stop the pump operation. The small amount is provided in case a small pressure is built up in the syringe, to ensure that all the air is removed. If the syringe is stuck, a pressure detector of the pump will alert of the pressure build up.
On the other hand, for a small syringe (5-10 ml), the pressure to start moving it may require a higher pressure. For example, it typically requires 1-2 levels of pressure to start the air drive to the syringe and a lower level of pressure to continue to drive it.
If desired, the pump may require the medical staff to input the volume of the syringe or collecting bag, typically prior to the first air removal. The pump may then alert the medical staff after the total air removed (over the course of a few removals) may reach the syringe volume.
Finally, air trap module 50 may include a syringe holder to physically block the syringe from jumping out of vent 18 if the pump operation was not stopped in time and resulted in an over flow.
While certain features of the invention have been illustrated and described herein, many modifications, substitutions, changes, and equivalents will now occur to those of ordinary skill in the art. It is, therefore, to be understood that the appended claims are intended to cover all such modifications and changes as fall within the true spirit of the invention.
This application claims benefit from U.S. Provisional Patent Application No. 61/282,858, filed Apr. 12, 2010, which is hereby incorporated in its entirety by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB2011/051586 | 4/12/2011 | WO | 00 | 1/15/2013 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2011/128850 | 10/20/2011 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2056322 | Hoppe | Oct 1936 | A |
2393838 | Tarbox | Jan 1946 | A |
2743898 | King | May 1956 | A |
2981115 | Beguin | Apr 1961 | A |
3443585 | Reinicke | May 1969 | A |
3511583 | Brown | May 1970 | A |
3677667 | Morrison | Jul 1972 | A |
3778195 | Bamberg | Dec 1973 | A |
3982722 | Bernard | Sep 1976 | A |
3982725 | Clark | Sep 1976 | A |
4014318 | Dockum et al. | Mar 1977 | A |
4039269 | Pickering | Aug 1977 | A |
4155362 | Jess | May 1979 | A |
4178138 | Iles | Dec 1979 | A |
4236880 | Archibald | Dec 1980 | A |
4270532 | Franetzki et al. | Jun 1981 | A |
4290346 | Bujan | Sep 1981 | A |
4320781 | Bouvet et al. | Mar 1982 | A |
4373525 | Kobayashi | Feb 1983 | A |
4450375 | Siegal | May 1984 | A |
4479797 | Kobayashi et al. | Oct 1984 | A |
4489863 | Horchos et al. | Dec 1984 | A |
4493706 | Borsanyi et al. | Jan 1985 | A |
4650469 | Berg et al. | Mar 1987 | A |
4671792 | Borsanyi | Jun 1987 | A |
4682135 | Yamakawa | Jul 1987 | A |
4690673 | Bloomquist | Sep 1987 | A |
4725205 | Cannon et al. | Feb 1988 | A |
4728265 | Cannon | Mar 1988 | A |
4741736 | Brown | May 1988 | A |
4748003 | Riley | May 1988 | A |
4755168 | Romanelli et al. | Jul 1988 | A |
4836752 | Burkett | Jun 1989 | A |
4867744 | Borsanyi | Sep 1989 | A |
4893991 | Heminway et al. | Jan 1990 | A |
4927411 | Pastrone et al. | May 1990 | A |
4954046 | Irvin et al. | Sep 1990 | A |
4954256 | Degen et al. | Sep 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
5061241 | Stephens, Jr. | Oct 1991 | A |
5074756 | Davis | Dec 1991 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5088904 | Okada | Feb 1992 | A |
5096385 | Georgi et al. | Mar 1992 | A |
5103211 | Daoud et al. | Apr 1992 | A |
5151019 | Danby et al. | Sep 1992 | A |
5152680 | Okada | Oct 1992 | A |
5165874 | Sancoff et al. | Nov 1992 | A |
5213483 | Flaherty et al. | May 1993 | A |
5219327 | Okada | Jun 1993 | A |
5222946 | Kamen | Jun 1993 | A |
5246347 | Davis | Sep 1993 | A |
5257978 | Haber et al. | Nov 1993 | A |
5286176 | Bonin | Feb 1994 | A |
5290158 | Okada | Mar 1994 | A |
5308333 | Skakoon | May 1994 | A |
5338157 | Blomquist | Aug 1994 | A |
5395320 | Padda et al. | Mar 1995 | A |
5429485 | Dodge | Jul 1995 | A |
5485408 | Blomquist | Jan 1996 | A |
5499969 | Beuchat et al. | Mar 1996 | A |
5509439 | Tantardini | Apr 1996 | A |
5527295 | Wing | Jun 1996 | A |
5542826 | Warner | Aug 1996 | A |
5569188 | Mackool | Oct 1996 | A |
5575309 | Connell | Nov 1996 | A |
5575631 | Jester | Nov 1996 | A |
5577891 | Loughnane et al. | Nov 1996 | A |
5584667 | Davis | Dec 1996 | A |
5593134 | Steber et al. | Jan 1997 | A |
5601420 | Warner et al. | Feb 1997 | A |
5628619 | Wilson | May 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5658252 | Johnson | Aug 1997 | A |
5660529 | Hill | Aug 1997 | A |
5669877 | Blomquist | Sep 1997 | A |
5683233 | Moubayed et al. | Nov 1997 | A |
5695473 | Olsen | Dec 1997 | A |
5704584 | Winterer et al. | Jan 1998 | A |
5742519 | McClendon et al. | Apr 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5788669 | Peterson | Aug 1998 | A |
5791880 | Wilson | Aug 1998 | A |
5791881 | Moubayed et al. | Aug 1998 | A |
5803712 | Davis et al. | Sep 1998 | A |
5807322 | Lindsey et al. | Sep 1998 | A |
5810323 | Winterer et al. | Sep 1998 | A |
5853386 | Davis et al. | Dec 1998 | A |
5876370 | Blomquist | Mar 1999 | A |
5888052 | Hill | Mar 1999 | A |
5896076 | Van Namen | Apr 1999 | A |
5909724 | Nishimura et al. | Jun 1999 | A |
5924852 | Moubayed et al. | Jul 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5935106 | Olsen | Aug 1999 | A |
5943633 | Wilson et al. | Aug 1999 | A |
5954485 | Johnson et al. | Sep 1999 | A |
5980490 | Tsoukalis | Nov 1999 | A |
5996964 | Ben-Shalom | Dec 1999 | A |
6024539 | Blomquist | Feb 2000 | A |
6095189 | Ben-Shalom | Aug 2000 | A |
6110153 | Davis et al. | Aug 2000 | A |
6146109 | Davis et al. | Nov 2000 | A |
6164921 | Moubayed et al. | Dec 2000 | A |
6165874 | Powell et al. | Dec 2000 | A |
RE37074 | Danby et al. | Feb 2001 | E |
6203296 | Ray et al. | Mar 2001 | B1 |
6213723 | Danby et al. | Apr 2001 | B1 |
6213739 | Phallen et al. | Apr 2001 | B1 |
6234773 | Hill et al. | May 2001 | B1 |
6241704 | Peterson et al. | Jun 2001 | B1 |
6261262 | Briggs et al. | Jul 2001 | B1 |
6280408 | Sipin | Aug 2001 | B1 |
6312227 | Davis | Nov 2001 | B1 |
6339410 | Milner et al. | Jan 2002 | B1 |
6347553 | Morris et al. | Feb 2002 | B1 |
6371732 | Moubayed et al. | Apr 2002 | B1 |
6422057 | Anderson | Jul 2002 | B1 |
6450773 | Upton | Sep 2002 | B1 |
6475180 | Peterson et al. | Nov 2002 | B2 |
6519569 | White et al. | Feb 2003 | B1 |
6537244 | Paukovits et al. | Mar 2003 | B2 |
6544171 | Beetz et al. | Apr 2003 | B2 |
6558347 | Jhuboo et al. | May 2003 | B1 |
6572604 | Platt et al. | Jun 2003 | B1 |
6622542 | Derek et al. | Sep 2003 | B2 |
6648861 | Platt et al. | Nov 2003 | B2 |
6692241 | Watanabe et al. | Feb 2004 | B2 |
6733476 | Christenson et al. | May 2004 | B2 |
6742992 | Davis | Jun 2004 | B2 |
6749587 | Flaherty | Jun 2004 | B2 |
6768425 | Flaherty et al. | Jul 2004 | B2 |
6788199 | Crabtree et al. | Sep 2004 | B2 |
6790198 | White et al. | Sep 2004 | B1 |
6902549 | Marmaropoulos et al. | Jun 2005 | B2 |
6942473 | Abrahamson et al. | Sep 2005 | B2 |
7018361 | Gillespie, Jr. et al. | Mar 2006 | B2 |
7022075 | Grunwald et al. | Apr 2006 | B2 |
7048720 | Thorne, Jr. et al. | May 2006 | B1 |
7059840 | Corwin et al. | Jun 2006 | B2 |
7122026 | Rogers et al. | Oct 2006 | B2 |
7131966 | Tamari | Nov 2006 | B1 |
7163385 | Gharib et al. | Jan 2007 | B2 |
7347836 | Peterson et al. | Mar 2008 | B2 |
7525432 | Jackson | Apr 2009 | B2 |
7556481 | Moubayed | Jul 2009 | B2 |
7645258 | White et al. | Jan 2010 | B2 |
7654976 | Peterson et al. | Feb 2010 | B2 |
7695255 | Ben-Shalom et al. | Apr 2010 | B2 |
7698156 | Martucci et al. | Apr 2010 | B2 |
7704227 | Moberg et al. | Apr 2010 | B2 |
7762795 | Moubayed | Jul 2010 | B2 |
7840260 | Epley | Nov 2010 | B2 |
7892332 | Prisco et al. | Feb 2011 | B2 |
7896834 | Smisson, III et al. | Mar 2011 | B2 |
7935102 | Breznock et al. | May 2011 | B2 |
7938796 | Moubayed et al. | May 2011 | B2 |
7963946 | Moubayed et al. | Jun 2011 | B2 |
7998121 | Stringham | Aug 2011 | B2 |
8025634 | Moubayed et al. | Sep 2011 | B1 |
8029253 | Rotem et al. | Oct 2011 | B2 |
8142400 | Rotem et al. | Mar 2012 | B2 |
8182445 | Moubayed et al. | May 2012 | B2 |
8197235 | Davis | Jun 2012 | B2 |
8214231 | Martucci et al. | Jul 2012 | B2 |
8234128 | Martucci et al. | Jul 2012 | B2 |
8241018 | Harr | Aug 2012 | B2 |
8257654 | Maus et al. | Sep 2012 | B2 |
8308457 | Rotem et al. | Nov 2012 | B2 |
8334768 | Eaton et al. | Dec 2012 | B2 |
8337168 | Rotem et al. | Dec 2012 | B2 |
8343111 | Beck et al. | Jan 2013 | B2 |
8352290 | Bartz et al. | Jan 2013 | B2 |
8363583 | Jia et al. | Jan 2013 | B2 |
8371832 | Rotem et al. | Feb 2013 | B2 |
8444587 | Kelly et al. | May 2013 | B2 |
8489427 | Simpson et al. | Jul 2013 | B2 |
8535025 | Rotem et al. | Sep 2013 | B2 |
8579816 | Kamath et al. | Nov 2013 | B2 |
8666367 | Sharp et al. | Mar 2014 | B2 |
8672875 | Vanderveen et al. | Mar 2014 | B2 |
8678793 | Goldor et al. | Mar 2014 | B2 |
8920144 | Rotem et al. | Dec 2014 | B2 |
9056160 | Rotem et al. | Jun 2015 | B2 |
20010029321 | Beetz et al. | Oct 2001 | A1 |
20020056675 | Hegde | May 2002 | A1 |
20020094287 | Davis | Jul 2002 | A1 |
20020156402 | Woog et al. | Oct 2002 | A1 |
20020165503 | Morris et al. | Nov 2002 | A1 |
20030034887 | Crabtree et al. | Feb 2003 | A1 |
20030040700 | Hickle et al. | Feb 2003 | A1 |
20030065536 | Hansen et al. | Apr 2003 | A1 |
20030109988 | Geissler et al. | Jun 2003 | A1 |
20030140928 | Bui et al. | Jul 2003 | A1 |
20030141981 | Bui et al. | Jul 2003 | A1 |
20030182586 | Numano | Sep 2003 | A1 |
20040167804 | Simpson et al. | Aug 2004 | A1 |
20040172222 | Simpson et al. | Sep 2004 | A1 |
20040181314 | Zaleski | Sep 2004 | A1 |
20040191112 | Hill et al. | Sep 2004 | A1 |
20040204673 | Flaherty | Oct 2004 | A1 |
20040204685 | Wright et al. | Oct 2004 | A1 |
20040235446 | Flaherty et al. | Nov 2004 | A1 |
20050001369 | Cross | Jan 2005 | A1 |
20050022274 | Campbell et al. | Jan 2005 | A1 |
20050055242 | Bello et al. | Mar 2005 | A1 |
20050088409 | Van Berkel | Apr 2005 | A1 |
20050112001 | Bahnen et al. | May 2005 | A1 |
20050171501 | Kelly | Aug 2005 | A1 |
20050191196 | Tanner et al. | Sep 2005 | A1 |
20050214146 | Corwin et al. | Sep 2005 | A1 |
20060051218 | Harttig | Mar 2006 | A1 |
20060083644 | Zumbrum et al. | Apr 2006 | A1 |
20060173419 | Malcolm | Aug 2006 | A1 |
20060213249 | Uram et al. | Sep 2006 | A1 |
20070032098 | Bowles et al. | Feb 2007 | A1 |
20070048161 | Moubayed | Mar 2007 | A1 |
20070060872 | Hall et al. | Mar 2007 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070135866 | Baker et al. | Jun 2007 | A1 |
20070154336 | Miyazaki et al. | Jul 2007 | A1 |
20070217931 | Estes et al. | Sep 2007 | A1 |
20070269324 | Goldor et al. | Nov 2007 | A1 |
20080015506 | Davis | Jan 2008 | A1 |
20080065007 | Peterson et al. | Mar 2008 | A1 |
20080065016 | Peterson et al. | Mar 2008 | A1 |
20080067462 | Miller et al. | Mar 2008 | A1 |
20080071251 | Moubayed et al. | Mar 2008 | A1 |
20080095649 | Ben-Shalom et al. | Apr 2008 | A1 |
20080144560 | Jia et al. | Jun 2008 | A1 |
20080145249 | Smisson et al. | Jun 2008 | A1 |
20080146995 | Smisson et al. | Jun 2008 | A1 |
20080275307 | Poschmann | Nov 2008 | A1 |
20090088675 | Kelly et al. | Apr 2009 | A1 |
20090163864 | Breznock et al. | Jun 2009 | A1 |
20090203329 | White et al. | Aug 2009 | A1 |
20090221964 | Rotem et al. | Sep 2009 | A1 |
20090240201 | Rotem et al. | Sep 2009 | A1 |
20090270810 | DeBelser et al. | Oct 2009 | A1 |
20090300507 | Raghavan et al. | Dec 2009 | A1 |
20090317268 | Rotem et al. | Dec 2009 | A1 |
20100016781 | Nakayama et al. | Jan 2010 | A1 |
20100036322 | Rotem | Feb 2010 | A1 |
20100082001 | Beck et al. | Apr 2010 | A1 |
20100168545 | Kamath et al. | Jul 2010 | A1 |
20100211002 | Davis | Aug 2010 | A1 |
20100228223 | Williams et al. | Sep 2010 | A1 |
20100234708 | Buck et al. | Sep 2010 | A1 |
20100279652 | Sharp et al. | Nov 2010 | A1 |
20110148624 | Eaton et al. | Jun 2011 | A1 |
20110152772 | Rotem et al. | Jun 2011 | A1 |
20110152831 | Rotem et al. | Jun 2011 | A1 |
20110167133 | Jain | Jul 2011 | A1 |
20110251856 | Maus et al. | Oct 2011 | A1 |
20110264043 | Kotnik et al. | Oct 2011 | A1 |
20110276000 | Stringham | Nov 2011 | A1 |
20110282291 | Ciccone | Nov 2011 | A1 |
20110318208 | Goldor et al. | Dec 2011 | A1 |
20120059389 | Larson et al. | Mar 2012 | A1 |
20120062387 | Vik et al. | Mar 2012 | A1 |
20120136305 | Gagliardoni et al. | May 2012 | A1 |
20120241525 | Borges et al. | Sep 2012 | A1 |
20130006666 | Schneider et al. | Jan 2013 | A1 |
20130046508 | Sur et al. | Feb 2013 | A1 |
20130116620 | Rotem et al. | May 2013 | A1 |
20130116623 | Rotem et al. | May 2013 | A1 |
20130142670 | Rotem et al. | Jun 2013 | A1 |
20130209275 | Rotem et al. | Aug 2013 | A1 |
20130279370 | Eitan et al. | Oct 2013 | A1 |
20130345623 | Kopperschmidt et al. | Dec 2013 | A1 |
20140005631 | Rotem et al. | Jan 2014 | A1 |
20140119954 | Schweitzer et al. | May 2014 | A1 |
20140197824 | Gillespie et al. | Jul 2014 | A1 |
20140222377 | Bitan et al. | Aug 2014 | A1 |
20140276564 | Schneider | Sep 2014 | A1 |
20140369872 | Goldor et al. | Dec 2014 | A1 |
20140378901 | Rotem et al. | Dec 2014 | A1 |
20150038187 | Ho et al. | Feb 2015 | A1 |
20150073338 | Waldhoff et al. | Mar 2015 | A1 |
20150105726 | Qi et al. | Apr 2015 | A1 |
20150137988 | Gravenstein et al. | May 2015 | A1 |
20150141955 | Ruchti et al. | May 2015 | A1 |
20150172921 | Wang et al. | Jun 2015 | A1 |
20150182694 | Rosinko | Jul 2015 | A1 |
20150192120 | Rotem et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
10118086 | Jul 2002 | DE |
0215249 | Mar 1987 | EP |
0225158 | Jun 1987 | EP |
0315312 | May 1989 | EP |
0429866 | Jun 1991 | EP |
0483794 | May 1992 | EP |
0858812 | Aug 1998 | EP |
1031358 | Aug 2000 | EP |
1350955 | Oct 2003 | EP |
1557186 | Jul 2005 | EP |
1611834 | Jan 2006 | EP |
1485149 | Jul 2008 | EP |
2632529 | Dec 1989 | FR |
2753236 | Mar 1998 | FR |
60043188 | Mar 1985 | JP |
6-169992 | Jun 1994 | JP |
2002-57738 | Feb 2002 | JP |
2004141418 | May 2004 | JP |
8400691 | Mar 1984 | WO |
9116933 | Nov 1991 | WO |
9325816 | Dec 1993 | WO |
9408647 | Apr 1994 | WO |
9603168 | Feb 1996 | WO |
9630679 | Oct 1996 | WO |
9734084 | Sep 1997 | WO |
9804301 | Feb 1998 | WO |
9813080 | Apr 1998 | WO |
9847551 | Oct 1998 | WO |
9958178 | Nov 1999 | WO |
0139816 | Jun 2001 | WO |
0165232 | Sep 2001 | WO |
0236044 | May 2002 | WO |
0238204 | May 2002 | WO |
0249509 | Jun 2002 | WO |
02068015 | Sep 2002 | WO |
03027503 | Apr 2003 | WO |
03080158 | Oct 2003 | WO |
2004070548 | Aug 2004 | WO |
2004093648 | Nov 2004 | WO |
2005089263 | Sep 2005 | WO |
2006056986 | Jun 2006 | WO |
2007133259 | Nov 2007 | WO |
2008036658 | Mar 2008 | WO |
2008059492 | May 2008 | WO |
2008059493 | May 2008 | WO |
2008059494 | May 2008 | WO |
2008059495 | May 2008 | WO |
2008059496 | May 2008 | WO |
2008059498 | May 2008 | WO |
2008059499 | May 2008 | WO |
2008130644 | Oct 2008 | WO |
2010053702 | May 2010 | WO |
2010053703 | May 2010 | WO |
2010091313 | Aug 2010 | WO |
2011128850 | Oct 2011 | WO |
2012095827 | Jul 2012 | WO |
2012095829 | Jul 2012 | WO |
2013001425 | Jan 2013 | WO |
2013028704 | Feb 2013 | WO |
2013090748 | Jun 2013 | WO |
Entry |
---|
Honeywell Sensing and Control, “FSSI500NSB force sensor”, Golden Valley, Minnesota, USA, 1998-2004 http://sccatalog.honeywell.com/imc/printfriendly.asp?FAM˜force&PN-FSSI500NSB (5 pages). |
International Application PCT/IL2007/001398 Search Report dated Jun. 11, 2008 (2 pages). |
International Application PCT/IL2007/001398 Patentability Report dated May 19, 2009 (6 pages). |
International Application PCT/IL2007/001399 Search Report dated Jun. 4, 2008 (3 pages). |
International Application PCT/IL2007/001399 Patentability Report dated May 19, 2009 (9 pages). |
International Application PCT/IL2007/001400 Search Report dated Jul. 15, 2008 (3 pages). |
International Application PCT/IL2007/001400 Patentability Report dated May 19, 2009 (10 pages). |
International Application PCT/IL2007/001401 Search Report dated Sep. 24, 2008 (2 pages). |
International Application PCT/IL2007/001401 Patentability Report dated May 19, 2009 (11 pages). |
International Application PCT/IL2007/001402 Search Report dated Jun. 20, 2008 (3 pages). |
International Application PCT/IL2007/001402 Patentability Report dated May 19, 2009 (4 pages). |
International Application PCT/IL2007/001404 Search Report dated Jul. 14, 2008 (2 pages). |
International Application PCT/IL2007/001404 Patentability Report dated May 19, 2009 (7 pages). |
International Application PCT/IL2007/001405 Search Report dated Jul. 21, 2008 (4 pages). |
International Application PCT/IL2007/001405 Patentability Report dated May 19, 2009 (7 pages). |
International Application PCT/IL2005/001249 Search Report dated Apr. 5, 2006 (18 pages). |
International Application PCT/IL1997/000289 Search report dated Jan. 27, 1998 (18 pages). |
International Application PCT/IL1997/000290 Search Report dated Jan. 27, 1998 (18 pages). |
International Application PCT/IL2003/000947 Search Report dated Mar. 3, 2004 (43 pages). |
International Application PCT/IB2011/051586 Search Report dated Oct. 27, 2011 (3 pages). |
International Application PCT/IB2011/051586 Patentability Report dated Oct. 16, 2012 (9 pages). |
International Application PCT/IB2012/050192 Search Report dated Aug. 17, 2012 (2 pages). |
International Application PCT/IB2012/050192 Patentability Report dated Jul. 16, 2013 (6 pages). |
International Application PCT/IB2012/050189 Search Report dated May 30, 2012 (2 pages). |
International Application PCT/IB2012/050189 Patentability Report dated Jul. 16, 2013 (5 pages). |
International Application PCT/IB2012/053149 Search Report dated Jan. 15, 2013 (2 pages). |
U.S. Appl. No. 09/125,438 Official Action dated May 3, 1999 (4 pages). |
U.S. Appl. No. 09/125,438 Official Action dated Jul. 15, 1999 (7 pages). |
U.S. Appl. No. 10/535,103 Official Action dated Feb. 2, 2009 (9 pages). |
European Application No. 05810500.8 Official Action dated Jul. 6, 2009 (5 pages). |
European Application No. 05810500.8 Response to Official Action dated Jul. 6, 2009, submitted Oct. 15, 2009 (8 pages). |
European Application No. 05810500.8 Official Action dated Jan. 23, 2012 (4 pages). |
European Application No. 05810500.8 Response to Official Action dated Jan. 23, 2012, submitted May 22, 2012 (6 pages). |
U.S. Appl. No. 11/791,599 Official Action (Non-Final) dated Aug. 19, 2010 (16 pages). |
U.S. Appl. No. 11/791,599 Response to Official Action (Non-Final) dated Aug. 19, 2010, submitted Jan. 11, 2011 (8 pages). |
U.S. Appl. No. 11/791,599 Official Action (Final) dated Mar. 31, 2011 (13 pages). |
U.S. Appl. No. 11/791,599 Response to Official Action (Final) dated Mar. 31, 2011, submitted May 23, 2011 (7 pages). |
U.S. Appl. No. 11/791,599 Notice of Allowance issued Jun. 14, 2011 (5 pages). |
U.S. Appl. No. 13/229,798 Official Action (Non-Final) dated Dec. 26, 2012 (10 pages). |
U.S. Appl. No. 13/229,798 Response to Official Action (Non-Final) dated Dec. 26, 2012, submitted Mar. 21, 2013 (13 pages). |
U.S. Appl. No. 13/229,798 Notice of Allowance issued Apr. 19, 2013 (6 pages). |
U.S. Appl. No. 13/229,798 Notice of Withdrawal from Issue dated May 13, 2013 (1 page). |
U.S. Appl. No. 13/229,798 Official Action (Non-Final) dated Jun. 21, 2013 (6 pages). |
Chinese Patent Application No. 200580045471.3 “Finger-type peristaltic pump” Official Action dated Jul. 18, 2008 and English translation thereof (7 pages). |
Chinese Patent Application No. 200780041966.8 Official Action dated Jul. 13, 2010 (7 pages). |
Chinese Patent Application No. 200780041966.8 Response to Official Action dated Jul. 13, 2010, as submitted (6 pages). |
Chinese Patent Application No. 200780041966.8, translation of Notification of Grant, issued Jan. 28, 2011 (2 pages). |
U.S. Appl. No. 12/464,202 Official Action (Non-Final) dated Oct. 3, 2011 (7 pages). |
U.S. Appl. No. 12/464,202 Response to Official Action (Non-Final) dated Oct. 3, 2011, submitted Feb. 12, 2012 (12 pages). |
U.S. Appl. No. 12/464,202 Notice of Allowance issued Jul. 11, 2012 (5 pages). |
U.S. Appl. No. 12/463,399 Official Action (Non-Final) dated Jul. 21, 2011 (15 pages). |
U.S. Appl. No. 12/463,399 Response to Official Action (Non-Final) dated Jul. 21, 2011, submitted Oct. 21, 2011 (5 pages). |
U.S. Appl. No. 12/463,399 Official Action (Final) dated Dec. 13, 2011 (7 pages). |
U.S. Appl. No. 12/463,399 Response to Official Action (Final) dated Dec. 13, 2011, submitted Feb. 12, 2012 (10 pages). |
U.S. Appl. No. 12/463,399 Advisory Action and Applicant Initiated Interview Summary dated Mar. 8, 2012 (8 pages). |
U.S. Appl. No. 12/463,399 Response to Official Action (Final) dated Dec. 13, 2011, submitted Mar. 26, 2012 with Request for Continued Examination (13 pages). |
U.S. Appl. No. 12/463,399 Notice of Allowance issued Apr. 29, 2013 (14 pages). |
U.S. Appl. No. 12/514,310 Official Action (Non-Final) dated Jul. 21, 2011 (8 pages). |
U.S. Appl. No. 12/514,310 Response to Official Action (Non-Final) dated Jul. 21, 2011, submitted Oct. 21, 2011 (8 pages). |
U.S. Appl. No. 12/514,310 Official Action (Final) dated Jan. 20, 2012 (10 pages). |
U.S. Appl. No. 12/514,310 Response to Official Action (Final) dated Jan. 20, 2012, submitted Apr. 25, 2012 with Request for Continued Examination (11 pages). |
U.S. Appl. No. 12/514,310 Official Action (Non-Final) dated May 25, 2012 (7 pages). |
U.S. Appl. No. 12/514,310 Response to Official Action (Non-Final) dated May 25, 2012, submitted Jun. 28, 2012 (6 pages). |
U.S. Appl. No. 12/514,310 Notice of Allowance issued Aug. 22, 2012 (7 pages). |
U.S. Appl. No. 12/514,311 Official Action (Non-Final) dated Sep. 16, 2010 (10 pages). |
U.S. Appl. No. 12/514,311 Response to Official Action (Non-Final) dated Sep. 16, 2010, submitted Dec. 9, 2010 (23 pages). |
U.S. Appl. No. 12/514,311 Official Action (Final) dated Feb. 18, 2011 (7 pages). |
U.S. Appl. No. 12/514,311 Examiner Interview Summary Record dated Mar. 4, 2011 (4 pages). |
U.S. Appl. No. 12/514,311 Response to Official Action (Final) dated Feb. 18, 2011, submitted Mar. 31, 2011 with Request for Continued Examination (9 pages). |
European Patent Application No. 10192477.7 Search Report dated May 10, 2011 (5 pages). |
European Patent Application No. 10192477.7 Response to Search Report dated May 10, 2011, submitted Dec. 28, 2011. |
U.S. Appl. No. 12/644,026 Official Action (Non-Final) dated Apr. 6, 2012 (12 pages). |
U.S. Appl. No. 12/644,026 Response to Official Action (Non-Final) dated Apr. 6, 2012, submitted Jul. 5, 2012 (11 pages). |
U.S. Appl. No. 12/644,026 Notice of Allowance issued Oct. 11, 2012 (10 pages). |
U.S. Appl. No. 13/742,454 Official Action (Non-Final) dated Oct. 7, 2013 (13 pages). |
U.S. Appl. No. 12/644,027 Official Action (Non-Final) dated Apr. 28, 2011 (7 pages). |
U.S. Appl. No. 12/644,027 Response to Official Action (Non-Final) dated Apr. 28, 2011, submitted Jul. 21, 2011 (10 pages). |
U.S. Appl. No. 12/644,027 Notice of Allowance issued Nov. 17, 2011 (5 pages). |
U.S. Appl. No. 13/229,798 Response to Official Action (Non-Final) dated Jun. 21, 2013, submitted Oct. 21, 2013 (3 pages). |
U.S. Appl. No. 13/229,798 Notice of Allowance issued Nov. 14, 2013 (54 pages). |
U.S. Appl. No. 13/651,420 Official Action (Non-Final) dated Nov. 4, 2013 (8 pages). |
U.S. Appl. No. 13/651,420 Response to Official Action (Non-Final) dated Nov. 4, 2013, submitted Nov. 21, 2013 (2 pages). |
U.S. Appl. No. 13/681,440 Official Action (Non-Final) dated Oct. 24, 2013 (11 pages). |
U.S. Appl. No. 13/651,420 Official Action (Non-Final) dated Jan. 6, 2014 (8 pages). |
U.S. Appl. No. 13/651,420 Response to Official Action (Non-Final) dated Jan. 6, 2014, submitted Mar. 5, 2014 (9 pages). |
U.S. Appl. No. 13/651,420 Official Action (Final) dated Apr. 24, 2014 (8 pages). |
U.S. Appl. No. 13/651,420 Response to Official Action (Final) dated Apr. 24, 2014, submitted Jul. 22, 2014 with Request for Continued Examination (15 pages). |
U.S. Appl. No. 13/651,420 Official Action (Non-Final) dated Aug. 19, 2014 (10 pages). |
U.S. Appl. No. 13/651,420 Response to Official Action (Non-Final) dated Aug. 19, 2014, submitted Dec. 18, 2014 (7 pages). |
U.S. Appl. No. 14/016,105 Official Action (Non-Final) dated Oct. 15, 2014 (10 pages). |
U.S. Appl. No. 13/681,440 Response to Official Action (Non-Final) dated Oct. 24, 2013, submitted Jan. 20, 2014 (10 pages). |
U.S. Appl. No. 13/681,440 Official Action (Final) dated Feb. 14, 2014 (14 pages). |
U.S. Appl. No. 13/681,440 Response to Official Action (Final) dated Feb. 14, 2014, submitted Jul. 14, 2014 with Request for Continued Examination (14 pages). |
U.S. Appl. No. 13/681,440 Official Action (Non-Final) dated Sep. 2, 2014 (19 pages). |
U.S. Appl. No. 12/514,311 Official Action (Non-Final) dated Oct. 7, 2014 (11 pages). |
U.S. Appl. No. 13/742,454 Response to Official Action (Non-Final) dated Oct. 7, 2013, submitted Jan. 6, 2014 (7 pages). |
U.S. Appl. No. 13/742,454 Official Action (Final) dated Mar. 28, 2014 (14 pages). |
U.S. Appl. No. 13/742,454 Response to Official Action (Final) dated Mar. 28, 2014, submitted Jun. 29, 2014 with Request for Continued Examination (10 pages). |
U.S. Appl. No. 13/742,454 Notice of Allowance issued Aug. 21, 2014 (10 pages). |
U.S. Appl. No. 13/640,519 Official Action (Non-Final) dated Dec. 24, 2013 (7 pages). |
U.S. Appl. No. 13/640,519 Response to Official Action (Non-Final) dated Dec. 24, 2013, submitted Jan. 16, 2014 (2 pages). |
U.S. Appl. No. 13/640,519 Official Action (Non-Final) dated Mar. 20, 2014 (15 pages). |
U.S. Appl. No. 13/640,519 Response to Official Action (Non-Final) dated Mar. 20, 2014, submitted Jun. 17, 2014 (14 pages). |
U.S. Appl. No. 13/640,519 Official Action (Final) dated Oct. 1, 2014 (11 pages). |
U.S. Appl. No. 13/924,572 Official Action (Non-Final) dated Dec. 2, 2014 (13 pages). |
European Application No. 11768544.6 Supplementary Partial European Search Report dated Nov. 13, 2014 (7 pages). |
European Application No. 12734200.4 Supplementary European Search Report dated Aug. 18, 2014 (6 pages). |
European Application No. 05810500.8 Official Action dated Nov. 3, 2014 (5 pages). |
European Application No. 05810500.8 Response to Official Action dated Nov. 3, 2014, submitted Mar. 9, 2015 (31 pages). |
Indian Patent Application No. 2344KOLNP2007 Office Action dated Dec. 31, 2014 (2 pages). |
Indian Patent Application No. 2344KOLNP2007 Response to Office Action dated Dec. 31, 2014, submitted Aug. 7, 2015 (19 pages). |
U.S. Appl. No. 14/181,673 Official Action (Non-Final) dated Jun. 3, 2015 (12 pages). |
U.S. Appl. No. 13/651,420 Official Action (Final) dated Mar. 16, 2015 (6 pages). |
U.S. Appl. No. 13/651,420 Response to Official Action (Final) dated Mar. 16, 2015, submitted May 14, 2015 (5 pages). |
U.S. Appl. No. 13/651,420 Official Action (Final) dated Jun. 9, 2015 (9 pages). |
U.S. Appl. No. 14/016,105 Response to Official Action (Non-Final) dated Oct. 15, 2014, submitted Jan. 14, 2015 (7 pages). |
U.S. Appl. No. 14/016,105 Notice of Allowance dated Feb. 17, 2015 (14 pages). |
U.S. Appl. No. 13/681,440 Response to Official Action (Non-Final) dated Sep. 2, 2014, submitted Feb. 25, 2015 (12 pages). |
U.S. Appl. No. 13/681,440 Official Action (Final) dated Apr. 24, 2015 (21 pages). |
U.S. Appl. No. 12/514,311 Response to Official Action (Non-Final) dated Oct. 7, 2014, submitted Jan. 7, 2015 (5 pages). |
U.S. Appl. No. 12/514,311 Official Action (Final) dated Apr. 20, 2015 (12 pages). |
U.S. Appl. No. 12/514,311 Response to Official Action (Final) dated Apr. 20, 2015, submitted Jun. 21, 2015 (10 pages). |
U.S. Appl. No. 12/514,311 Official Action (Advisory Action) dated Jul. 1, 2015 (8 pages). |
U.S. Appl. No. 12/514,311 Response to Official Action (Advisory Action) dated Jul. 1, 2015, submitted Jul. 20, 2015 (8 pages). |
U.S. Appl. No. 12/514,311 Official Action (Advisory Action) dated Aug. 5, 2015 (6 pages). |
European Application No. 10192477.7 Official Action dated Jul. 6, 2015 (5 pages). |
European Application No. 11768544.6 Response to Official Action dated Dec. 2, 2014, submitted May 29, 2015 (12 pages). |
U.S. Appl. No. 13/640,519 Response to Official Action (Final) dated Oct. 1, 2014, submitted Dec. 28, 2014 (15 pages). |
U.S. Appl. No. 13/640,519 Official Action (Non-Final) dated May 6, 2015 (13 pages). |
European Application No. 12734200.4 Response to Official Communication dated Sep. 4, 2014, submitted Mar. 4, 2015 (16 pages). |
U.S. Appl. No. 13/978,538 Official Action (Non-Final) dated Jan. 23, 2015 (24 pages). |
U.S. Appl. No. 13/978,538 Response to Official Action (Non-Final) dated Jan. 23, 2015, submitted May 21, 2015 (13 pages). |
U.S. Appl. No. 13/978,538 Official Action (Non-Final) dated Jul. 24, 2015 (16 pages). |
European Application No. 12805094.5 Supplementary Partial European Search Report dated Feb. 23, 2015 (8 pages). |
European Application No. 12805094.5 Response to Supplementary Partial European Search Report submitted Apr. 2, 2015 (1 page). |
European Application No. 12805094.5 Supplementary European Search Report dated Jun. 30, 2015 (14 pages). |
U.S. Appl. No. 13/924,572 Response to Official Action (Non-Final) dated Dec. 2, 2014, submitted Mar. 26, 2015 (11 pages). |
U.S. Appl. No. 13/924,572 Official Action (Non-Final) dated May 14, 2015 (12 pages). |
PCT Appl. No. PCT/IB14/62106 International Search Report and Written Opinion dated Feb. 24, 2015 (8 pages). |
PCT Appl. No. PCT/IB15/50873 International Search Report and Written Opinion dated Jun. 25, 2015 (8 pages). |
Number | Date | Country | |
---|---|---|---|
20130116620 A1 | May 2013 | US |
Number | Date | Country | |
---|---|---|---|
61282858 | Apr 2010 | US |